Form 4: TransDigm COO Joel Reiss Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report


TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and subsequently sold 3,900 shares of common stock in a pre-planned transaction.

Summary

  • Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC (TDG), engaged in a series of transactions on January 15, 2026.
  • Reiss acquired 3,900 shares of common stock by exercising stock options at a price of $284.97 per share.
  • Concurrently, Reiss disposed of 3,900 shares of common stock through multiple sales.
  • The sales occurred at weighted average prices ranging from $1,420.375 to $1,438.9075 per share.
  • These transactions were conducted pursuant to a Rule 10b5-1(c) pre-planned trading arrangement.
  • Following these transactions, Reiss directly beneficially owns 3,600 shares of common stock and 35,300 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the transaction was pre-planned under a 10b5-1 plan, mitigating concerns about opportunistic selling. The executive realized significant value from options, which is a positive for the individual and reflects past stock appreciation.

Positives

  • The exercise of stock options indicates the executive is realizing value from their compensation plan.
  • The sale prices for the common stock were significantly higher than the exercise price of $284.97, indicating substantial personal gain for the executive.
  • The transactions were conducted under a Rule 10b5-1(c) plan, suggesting they were pre-scheduled and not based on immediate, non-public information.

Negatives

  • The sale of 3,900 shares by a Co-Chief Operating Officer could be interpreted by some investors as a reduction in insider exposure to the company's stock.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of insider trading activity and does not provide information to assess broader industry trends or competitive landscape. It reflects an executive's personal financial planning rather than a strategic company move.

Stakeholder Impact

  • Shareholders: May view the insider sale with slight caution, though the 10b5-1 plan mitigates concerns. The executive still retains a significant number of options and some direct shares.
  • Employees: No direct impact.
  • Customers/Suppliers/Creditors: No direct impact.

Key Dates

DateDescription
09/30/2021Date stock option became exercisable.
01/15/2026Date of stock option exercise and subsequent common stock sales.
01/16/2026Date the Form 4 was signed.
11/08/2027Expiration date of the stock option.

Keywords

TransDigm Group, TDG, Joel Reiss, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Executive Compensation, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.